Company Filing History:
Years Active: 2020
Title: Mamidi Srinivas: Innovator in Pharmaceutical Chemistry
Introduction
Mamidi Srinivas is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing complex compounds. His work is characterized by a focus on achieving high optical purity in chemical preparations.
Latest Patents
Srinivas holds a patent for a method titled "Method for preparing (R)-N-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide." This innovative method allows for the preparation of N-[4-[(1R)-1-[[(R)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-2,6-difluorophenyl]-methanesulfonamide (INT028-2) with high optical purity. The process involves the selection of Ellman-chiral auxiliaries and the recrystallization and separation of optical isomers. This method enables the production of high-purity compounds at room temperature, significantly reducing the failure rate associated with cryogenic processes.
Career Highlights
Srinivas is currently employed at Amorepacific Corporation, where he continues to apply his expertise in pharmaceutical innovations. His work has not only advanced the field but has also contributed to the development of new therapeutic agents.
Collaborations
He has collaborated with esteemed colleagues, including Byoung Young Woo and Ki-Wha Lee, to further enhance the research and development efforts within his organization.
Conclusion
Mamidi Srinivas is a distinguished inventor whose contributions to pharmaceutical chemistry have paved the way for advancements in drug development. His innovative methods and collaborative spirit continue to inspire progress in the field.